Aggregates of a protein spread in the brains of people with Parkinson’s disease through a cellular waste-ejection process, suggests a new study led by Weill Cornell Medicine researchers.
A series of free, evidence-informed apps for preschool-aged children, developed by a Cornell researcher and colleagues, aims to encourage healthy eating behaviors and exercise.
Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer.
Researchers have uncovered a novel pathway that explains how cancer cells become resistant to chemotherapies, which in turn offers a potential solution for preventing chemo-resistance.
Paula Cohen, professor of genetics, is pioneering an innovative alternative to the birth control pill: a form of male contraception that targets a mechanism in the early stage of sperm cell production.
Six Cornell faculty members from three different colleges will work together to improve epidemiological models of infectious disease, including by better incorporating human behavior into the models, using a $1 million grant from the National Science Foundation.
A team of researchers has discovered a non-invasive biomarker that could aid with earlier diagnosis of breast cancer, the most common cancer among women, which will likely affect one in 13 women during their lives.
